Fecal Microbiota Transplant (FMT)
Transfer of screened donor stool to restore a healthy gut microbiome, done by a clinician.
90/100
Various (clinical researchers)
Single treatment or a short series, as your clinician decides
7 phases
2 conditions
Protocol Overview
Transfer of screened donor stool to restore a healthy gut microbiome, done by a clinician. Two FDA-approved fecal microbiota products are used to prevent recurrent C. diff infection in adults after antibiotic treatment: a rectal product approved in November 2022 and oral capsules approved in April 2023. Other uses are experimental.
Used For
Key Resources
Safety Profile
In trials, FMT stops C. diff from coming back in most people with recurrent infection. Results for ulcerative colitis are promising but modest, and evidence for IBS and other conditions is mixed. In 2019 the FDA reported serious drug-resistant infections, including one death, from donor stool that had not been screened for those bacteria.
Find a Practitioner
Gabriel can find and book a practitioner who works with this approach.
Book with GabrielAbout Evidence Score
The Evidence Score (0 to 100) rates the strength of evidence from studies in people for the uses listed: higher means stronger, more consistent research. It does not measure safety. It is not medical advice.
For education, not medical advice. Talk with a licensed clinician before you start, and never stop or change a prescribed medication without your prescriber.